The Relationship between BRAF V600E Mutation and the Clinicopathological Features of the Papillary Thyroid Carcinoma

Abstract

Retraction type (multiple responses allowed):  Unreliable findings   Lab error  Inconsistent data  Analytical error  Biased interpretation   Other:  Irreproducible results  Failure to disclose a major competing interest likely to influence interpretations or recommendations  Unethical research   Fraud   Data fabrication  Fake publication  Other:  Plagiarism  Self plagiarism  Overlap  Redundant publication *  Copyright infringement  Other legal concern:  Editorial reasons   Handling error  Unreliable review(s)  Decision error  Other: ✘ Other: Results of publication (only one response allowed): ✘ are still valid.  were found to be overall invalid.

The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience

“…Some clinical features and tests help diagnose this disease, including bone marrow (BM) biopsy, high hemoglobin, and hematocrit, abnormal level of serum erythropoietin, leukocytosis, increased LDL, and splenomegaly (4). Different studies reported that the determination of some special mutations can be valuable in the screening and diagnosis of different diseases and treatment of patients (5,6). The co-occurrence of these three mutations has been documented.…”